Weekly 60K Softgel Capsule contains Vitamin D3 (Cholecalciferol) at a potency of 60,000 IU per capsule, designed for the management and prevention of vitamin D deficiency and insufficiency. Vitamin D3 plays a crucial role in calcium and phosphorus homeostasis, promoting optimal bone mineralization and supporting musculoskeletal health. This high-dose formulation is typically prescribed for patients with documented vitamin D deficiency, osteomalacia, rickets, or conditions requiring rapid correction of serum vitamin D levels. The softgel capsule facilitates ease of administration and enhances bioavailability. Weekly dosing ensures sustained therapeutic levels while improving patient compliance compared to daily regimens. Vitamin D3 is metabolized in the liver to 25-hydroxyvitamin D, the major circulating form, and subsequently activated in the kidneys to 1,25-dihydroxyvitamin D, which exerts biological effects on target tissues. Monitoring serum 25-hydroxyvitamin D concentrations is recommended during therapy to avoid toxicity. Contraindications include hypercalcemia, hypervitaminosis D, and hypersensitivity to any component of the formulation. Adverse effects are rare but may include hypercalcemia symptoms such as nausea, vomiting, and weakness if overdosed. Weekly 60K Softgel Capsule should be used under medical supervision to ensure safe and effective correction of vitamin D status.